Jordis J Ott
Overview
Explore the profile of Jordis J Ott including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
1601
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kessel B, Heinsohn T, Ott J, Wolff J, Hassenstein M, Lange B
PLOS Glob Public Health
. 2023 May;
3(5):e0001018.
PMID: 37126484
COVID-19 pandemic puts an enormous strain on health care systems worldwide and may have a detrimental effect on prevention, treatment and outcomes of tuberculosis (TB), viral hepatitis, HIV/AIDS and malaria,...
2.
Umutesi J, Nsanzimana S, Yingkai Liu C, Vanella P, Ott J, Krause G
BMC Infect Dis
. 2022 May;
22(1):500.
PMID: 35624437
Background: There remain gaps in quantifying mortality risk among individuals co-infected with chronic hepatitis B (HBV) and human immunodeficiency virus (HIV) in sub-Saharan African contexts. Among a cohort of HIV-positive...
3.
Nguyen M, Krause G, Keller-Stanislawski B, Glockner S, Mentzer D, Ott J
JMIR Mhealth Uhealth
. 2021 May;
9(5):e26289.
PMID: 33960950
Background: For the safety monitoring of vaccinations postlicensure, reports of adverse events after immunization (AEFIs) are crucial. New technologies such as digital mobile apps can be used as an active...
4.
Hassenstein M, Aarabi G, Ahnert P, Becher H, Franzke C, Fricke J, et al.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
. 2020 Mar;
63(4):404-414.
PMID: 32185449
Background: Infectious diseases continue to play an important role for disease perception, health-economic considerations and public health in Germany. In recent years, infectious diseases have been linked to the development...
5.
Velkov S, Ott J, Protzer U, Michler T
Genes (Basel)
. 2018 Oct;
9(10).
PMID: 30326600
Hepatitis B virus (HBV) is divided into nine genotypes, A to I. Currently, it remains unclear how the individual genotypes contribute to the estimated 250 million chronic HBV infections. We...
6.
Horn J, Hoodgarzadeh M, Klett-Tammen C, Mikolajczyk R, Krause G, Ott J
J Infect
. 2018 Oct;
77(6):544-552.
PMID: 30268515
Objectives: Reliable epidemiologic estimates of Hepatitis E Virus (HEV) infection and evidence on factors determining country-differences are sparse. We systematically assessed and extracted research data on three HEV infection markers...
7.
Lemon S, Ott J, Van Damme P, Shouval D
J Hepatol
. 2017 Sep;
PMID: 28887164
Although epidemic jaundice was well known to physicians of antiquity, it is only in recent years that medical science has begun to unravel the origins of hepatitis A virus (HAV)...
8.
Ott J, Horn J, Krause G, Mikolajczyk R
J Hepatol
. 2016 Sep;
66(1):48-54.
PMID: 27592304
Background & Aims: Information on trends in chronic hepatitis B virus (HBV) prevalence across countries is lacking. We studied changes in chronic HBV infection over previous decades by country, and...
9.
10.
Klett-Tammen C, Krause G, Seefeld L, Ott J
BMC Public Health
. 2016 Feb;
16:121.
PMID: 26846202
Background: Severity and incidence of vaccine-preventable infections with influenza viruses, s. pneumoniae and c. tetani increase with age. Furthermore, vaccine coverage in the elderly is often insufficient. The aim of...